Pepcid: Advanced Acid Control for Lasting Relief
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 56 | $1.07 | $60.20 (0%) | 🛒 Add to cart |
| 84 | $1.02 | $90.30 $86.00 (5%) | 🛒 Add to cart |
| 112 | $0.92 | $120.40 $103.20 (14%) | 🛒 Add to cart |
| 168 | $0.72 | $180.60 $120.40 (33%) | 🛒 Add to cart |
| 224 | $0.61 | $240.80 $137.60 (43%) | 🛒 Add to cart |
| 336 | $0.54
Best per pill | $361.20 $180.60 (50%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 56 | $1.23 | $68.80 (0%) | 🛒 Add to cart |
| 84 | $1.13 | $103.20 $94.60 (8%) | 🛒 Add to cart |
| 112 | $1.00 | $137.60 $111.80 (19%) | 🛒 Add to cart |
| 168 | $0.77 | $206.40 $129.00 (37%) | 🛒 Add to cart |
| 224 | $0.69 | $275.20 $154.80 (44%) | 🛒 Add to cart |
| 336 | $0.63
Best per pill | $412.80 $210.70 (49%) | 🛒 Add to cart |
Synonyms | |||
Pepcid (famotidine) is a histamine-2 (H2) blocker medication clinically proven to reduce stomach acid production effectively. It is indicated for the short-term treatment of active duodenal ulcers, maintenance therapy for healed duodenal ulcers, treatment of active benign gastric ulcers, and management of gastroesophageal reflux disease (GERD). Additionally, it is used for the treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome. By competitively inhibiting histamine at H2 receptors of gastric parietal cells, Pepcid provides sustained acid suppression, facilitating mucosal healing and symptom relief in acid-related disorders.
Features
- Active ingredient: Famotidine 10mg or 20mg per tablet
- Formulation: Oral tablets, chewable tablets, and oral suspension
- Onset of action: Within 1 hour
- Duration of acid suppression: Up to 12 hours
- Prescription and over-the-counter (OTC) variants available
- Non-antacid mechanism; does not neutralize existing acid
Benefits
- Provides rapid and prolonged relief from heartburn, acid indigestion, and sour stomach
- Reduces the frequency and severity of GERD symptoms, including regurgitation and chest discomfort
- Promotes healing of erosive esophagitis and duodenal ulcers when used as directed
- Minimizes nocturnal acid breakthrough, improving sleep quality in patients with nighttime symptoms
- Offers flexible dosing options suitable for both acute intervention and maintenance therapy
- Lower risk of systemic side effects compared to proton pump inhibitors (PPIs) in certain patient populations
Common use
Pepcid is commonly used for the management of conditions associated with gastric acid hypersecretion. This includes the treatment of active duodenal and gastric ulcers, maintenance therapy for duodenal ulcer prevention, and symptomatic relief in GERD. It is also utilized in managing heartburn and acid indigestion on an as-needed basis in its OTC form. In clinical settings, it may be administered preoperatively to reduce the risk of acid aspiration syndrome. Off-label uses include adjunctive therapy for stress ulcer prophylaxis in critically ill patients.
Dosage and direction
For active duodenal ulcer: 40 mg once daily at bedtime, or 20 mg twice daily for 4–8 weeks.
For maintenance of healed duodenal ulcer: 20 mg once daily at bedtime.
For GERD: 20 mg twice daily for up to 6 weeks.
For OTC heartburn relief: 10 mg to 20 mg as needed, not to exceed two doses in 24 hours.
Tablets should be swallowed whole with water; chewable tablets must be thoroughly chewed before swallowing.
Dosage adjustments are necessary in patients with renal impairment (CrCl <50 mL/min).
Precautions
Use with caution in patients with a history of porphyria. Renal function should be assessed prior to and during prolonged therapy. Long-term use may lead to vitamin B12 deficiency due to reduced acid-mediated absorption. There is a potential risk of cross-sensitivity with other H2 antagonists. Use in elderly patients may require dose adjustment due to reduced renal clearance. Not recommended for use beyond 14 days in OTC settings without medical consultation.
Contraindications
Hypersensitivity to famotidine or any component of the formulation. Contraindicated in patients with a history of acute porphyria. Should not be used in patients taking atazanavir due to significant reduction in atazanavir plasma concentrations.
Possible side effects
Common: Headache (4.7%), dizziness (1.3%), constipation (1.2%), diarrhea (1.7%).
Less common: Dry mouth, fatigue, mild and transient elevation of liver enzymes.
Rare: Confusion, agitation, depression, hallucinations (particularly in elderly or severely ill patients), thrombocytopenia, agranulocytosis, anaphylaxis.
Prolonged use may be associated with increased risk of infections due to reduced gastric acidity.
Drug interaction
May decrease absorption of ketoconazole, itraconazole, and atazanavir due to increased gastric pH.
Famotidine may alter the absorption of pH-dependent drugs.
No significant interaction with cytochrome P450 enzymes; however, caution is advised with drugs that require acidic environment for absorption.
Concomitant use with high-dose antacids is not recommended due to potential reduced famotidine bioavailability.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Maintain the regular dosing schedule. For OTC use, adhere to the recommended dosing interval of every 12 hours as needed.
Overdose
Symptoms may include hypotension, tachycardia, and central nervous system effects such as agitation and vomiting. Management is supportive; gastric lavage may be considered if ingestion is recent. Hemodialysis removes approximately 65% of circulating famotidine and may be employed in severe cases. There is no specific antidote.
Storage
Store at room temperature (20–25°C or 68–77°F). Protect from moisture and light. Keep the container tightly closed. Do not use if the product shows signs of deterioration or discoloration. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting or altering any medication regimen. Do not use Pepcid for longer than directed on the label or by a physician. Seek immediate medical attention in case of severe symptoms such as difficulty swallowing, vomiting blood, or unintended weight loss.
Reviews
Clinical studies demonstrate that famotidine 20 mg twice daily provides effective symptom relief in 70–80% of GERD patients within 2 weeks. Endoscopic healing rates for duodenal ulcers approach 90% after 8 weeks of therapy at 40 mg daily. Patient-reported outcomes indicate high satisfaction with rapid onset of action and convenient dosing. Long-term safety data support its use for maintenance therapy, with a favorable side effect profile compared to other acid-suppressing agents.